Introduction: Achilles tendon rupture (ATR) carries a high risk of venous thrombo-embolism (VTE) whether the injury is managed surgically or non-operatively. This study reports symptomatic VTE rate following ATR. The influence of patient demographics, treatment type and use of chemical thromboprophylaxis is examined.
Materials And Methods: Observational cohort study. The data is from a multi-centre, prospective, national audit of patients from 68 participating United Kingdom centres. Data was prospectively collected from hospital records. The study was conducted between June and November 2022, with a 3-month follow up.
Results: Of 11,363 participants in the National Audit, 9.5 % (n = 1084) had experienced an ATR. Management strategies included both non-surgical (74 %) and surgical (26 %). Following ATR, the VTE rate was 3.69 % (n = 40) compared to 0.57 % (n = 59) for other foot and ankle surgeries. Participants who developed symptomatic VTE after ATR were older than those who did not (mean age 54 years (95 %CI 50.5 - 54.7) vs 48 years (95 %CI 47.3 - 49.1)). There was no significant difference in VTE events due to participant sex, ethnicity or number of comorbidities. Differences in treatment regimen, such as weight-bearing status and immobilisation strategy, showed no significant difference in symptomatic VTE events between groups.
Conclusion: After ATR, patients are 6.5-times more likely to experience symptomatic VTE than those recovering from surgery for other foot and ankle pathology. There was no significant difference in symptomatic VTE rate after ATR with specific chemical prophylaxis or early mobilisation strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.injury.2025.112212 | DOI Listing |
Eur J Surg Oncol
February 2025
Department of Surgery, The Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.
Background: Extended duration postoperative thromboprophylaxis is suggested by clinical practice guidelines after any cancer-related major abdominal surgeries. However, recent evidence reported relatively low rates of symptomatic venous thromboembolism (VTE) after colorectal cancer surgeries, suggesting the need of a careful risk-benefit assessment in this setting.
Methods: This is a pre-planned post-hoc analysis of the PERIOP-01 trial which compared extended to standard thromboprophylaxis in patients undergoing surgical resection of localized colorectal cancer.
Am Heart J
June 2025
Respiratory Unit, Virgen del Rocio University Hospital, Seville, Spain; CIBERES, Carlos III Health Institute, Madrid, Spain; Biomedical Institute of Sevilla, Seville, Spain. Electronic address:
Background: Unprovoked venous thromboembolism (VTE) is considered when no clear major provoking factor for VTE is identified. Although the 1-year risk of diagnosing new cancer in these patients can be as high as 5%, the benefits of extensive screening remain uncertain. It is possible that in a risk-enriched population of patients, screening yields benefit.
View Article and Find Full Text PDFInjury
March 2025
University Hospitals of Leicester NHS Trust, Leicester, UK; University of Leicester, School of Healthcare, Leicester, UK.
Introduction: Achilles tendon rupture (ATR) carries a high risk of venous thrombo-embolism (VTE) whether the injury is managed surgically or non-operatively. This study reports symptomatic VTE rate following ATR. The influence of patient demographics, treatment type and use of chemical thromboprophylaxis is examined.
View Article and Find Full Text PDFNeurosurg Pract
December 2024
Department of Neurosurgery, University Hospital Halle, Halle, Germany.
Background And Objective: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication in craniotomy patients. The duration of surgery has been identified as a risk factor for the development of VTE. In a pilot study, the use of intermittent pneumatic venous compression (IPC) dramatically reduced the incidence of VTE.
View Article and Find Full Text PDFClin Appl Thromb Hemost
February 2025
Department of Medicine, Anne Arundel Medical Center, Annapolis, MD, USA.
Background: The study's main aim was to determine the prevalence of elevated D-dimer levels in adult patients hospitalized for acute medical illnesses not suspected to have venous thromboembolism (VTE). The secondary aims were to determine VTE prophylaxis rates and VTE events.
Methods: This multicenter, prospective, observational study included patients who were admitted across nine US hospitals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!